Surgical Phase Duration in Robot-Assisted Partial Nephrectomy: A Surgical Data Science Exploration for Clinical Relevance.
partial nephrectomy
phase duration assessment
surgical data science
video analysis
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
05 Nov 2023
05 Nov 2023
Historique:
received:
25
08
2023
revised:
29
10
2023
accepted:
03
11
2023
medline:
14
11
2023
pubmed:
14
11
2023
entrez:
14
11
2023
Statut:
epublish
Résumé
(1) Background: Surgical phases form the basic building blocks for surgical skill assessment, feedback, and teaching. The phase duration itself and its correlation with clinical parameters at diagnosis have not yet been investigated. Novel commercial platforms provide phase indications but have not been assessed for accuracy yet. (2) Methods: We assessed 100 robot-assisted partial nephrectomy videos for phase durations based on previously defined proficiency metrics. We developed an annotation framework and subsequently compared our annotations to an existing commercial solution (Touch Surgery, Medtronic™). We subsequently explored clinical correlations between phase durations and parameters derived from diagnosis and treatment. (3) Results: An objective and uniform phase assessment requires precise definitions derived from an iterative revision process. A comparison to a commercial solution shows large differences in definitions across phases. BMI and the duration of renal tumor identification are positively correlated, as are tumor complexity and both tumor excision and renorrhaphy duration. (4) Conclusions: The surgical phase duration can be correlated with certain clinical outcomes. Further research should investigate whether the retrieved correlations are also clinically meaningful. This requires an increase in dataset sizes and facilitation through intelligent computer vision algorithms. Commercial platforms can facilitate this dataset expansion and help unlock the full potential, provided that the phase annotation details are disclosed.
Identifiants
pubmed: 37958283
pii: diagnostics13213386
doi: 10.3390/diagnostics13213386
pmc: PMC10650909
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Flanders Innovation and Entrepreneurship
ID : HBC.2020.2252
Organisme : Ipsen NV
ID : A20/TT/1655
Références
Patient Saf Surg. 2014 May 27;8:23
pubmed: 24932219
Eur Urol Focus. 2023 Mar;9(2):388-395
pubmed: 36229343
Surg Endosc. 2023 Mar;37(3):2070-2077
pubmed: 36289088
Eur Urol. 2023 May;83(5):413-421
pubmed: 36737298
Eur Urol Open Sci. 2023 Jan 30;49:71-77
pubmed: 36874602
Ann Surg. 2021 Apr 1;273(4):684-693
pubmed: 33201088
Ann Surg. 2016 Jul;264(1):32-3
pubmed: 26756757
Surgery (Oxf). 2020 Oct;38(10):617-622
pubmed: 32904575
Surg Infect (Larchmt). 2017 Aug/Sep;18(6):722-735
pubmed: 28832271
JAMA Surg. 2015 Feb;150(2):110-7
pubmed: 25472485
Cancers (Basel). 2023 Mar 16;15(6):
pubmed: 36980679
Surgeon. 2019 Dec;17(6):334-339
pubmed: 30420320
Langenbecks Arch Surg. 2023 Feb 20;408(1):95
pubmed: 36807211
Surg Innov. 2019 Feb;26(1):95-111
pubmed: 30465477
Surg Endosc. 2023 Nov;37(11):8690-8707
pubmed: 37516693
Ann Surg. 2021 Aug 1;274(2):281-289
pubmed: 33630473
Ann Surg. 2017 Dec;266(6):934-936
pubmed: 28338514
Surg Endosc. 2011 Jul;25(7):2288-95
pubmed: 21298533
Nat Biomed Eng. 2017 Sep;1(9):691-696
pubmed: 31015666
BJU Int. 2021 Jul;128(1):103-111
pubmed: 33251703
JAMA Surg. 2020 Nov 1;155(11):1078-1079
pubmed: 32902619
NPJ Digit Med. 2022 Oct 28;5(1):163
pubmed: 36307544
J Robot Surg. 2023 Aug;17(4):1401-1409
pubmed: 36689078
Surg Endosc. 2022 Nov;36(11):8533-8548
pubmed: 35941310
Surg Endosc. 2022 Nov;36(11):7938-7948
pubmed: 35556166
J Surg Educ. 2015 Nov-Dec;72(6):e145-50
pubmed: 26454723
Int J Comput Assist Radiol Surg. 2018 Sep;13(9):1397-1408
pubmed: 30006820
Minerva Urol Nephrol. 2021 Oct;73(5):564-571
pubmed: 32182230
J Surg Educ. 2018 May - Jun;75(3):828-835
pubmed: 29031522